IRIS UniCatt

Albanese, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.394
AS - Asia 6.432
EU - Europa 5.927
SA - Sud America 1.512
AF - Africa 171
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 8
Totale 21.459
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.208
SG - Singapore 2.921
DE - Germania 1.947
CN - Cina 1.531
BR - Brasile 1.233
SE - Svezia 850
UA - Ucraina 705
FR - Francia 633
VN - Vietnam 614
IT - Italia 471
IE - Irlanda 382
ID - Indonesia 245
GB - Regno Unito 238
IN - India 213
JP - Giappone 210
RU - Federazione Russa 189
FI - Finlandia 162
HK - Hong Kong 151
TR - Turchia 124
AR - Argentina 102
BD - Bangladesh 97
AT - Austria 71
IQ - Iraq 70
MX - Messico 67
CA - Canada 62
NL - Olanda 53
EC - Ecuador 51
PL - Polonia 50
ZA - Sudafrica 44
CO - Colombia 33
PK - Pakistan 32
BE - Belgio 28
CI - Costa d'Avorio 27
ES - Italia 27
SA - Arabia Saudita 26
VE - Venezuela 25
UZ - Uzbekistan 23
MA - Marocco 21
CL - Cile 19
PE - Perù 18
DZ - Algeria 16
EG - Egitto 16
KR - Corea 16
IR - Iran 13
JO - Giordania 13
PY - Paraguay 13
TN - Tunisia 13
AU - Australia 12
KE - Kenya 12
PH - Filippine 12
BG - Bulgaria 11
IL - Israele 11
AE - Emirati Arabi Uniti 10
JM - Giamaica 10
KZ - Kazakistan 10
NP - Nepal 10
RO - Romania 10
AZ - Azerbaigian 9
GR - Grecia 9
HU - Ungheria 9
MY - Malesia 9
PA - Panama 9
BO - Bolivia 8
CR - Costa Rica 8
CZ - Repubblica Ceca 8
EE - Estonia 8
LT - Lituania 8
MD - Moldavia 8
OM - Oman 8
UY - Uruguay 8
ET - Etiopia 7
HN - Honduras 7
CH - Svizzera 6
SI - Slovenia 6
TH - Thailandia 6
BH - Bahrain 5
BY - Bielorussia 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
EU - Europa 5
KG - Kirghizistan 5
LB - Libano 5
NO - Norvegia 5
TW - Taiwan 5
AL - Albania 4
AM - Armenia 4
KW - Kuwait 4
NI - Nicaragua 4
QA - Qatar 4
RS - Serbia 4
SN - Senegal 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
LK - Sri Lanka 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
Totale 21.424
Salva come PNG Salva come JPEG
Città #
Singapore 1.382
Ashburn 937
San Jose 932
Chandler 869
Dublin 380
San Mateo 338
Jacksonville 321
Beijing 299
Jakarta 218
Nanjing 207
Ho Chi Minh City 201
Lauterbourg 186
Tokyo 185
Wilmington 179
Hanoi 160
New York 146
Hong Kong 141
Los Angeles 125
Hefei 124
Boston 119
Dallas 117
Lawrence 116
Dearborn 113
Ann Arbor 106
Moscow 104
Woodbridge 102
São Paulo 95
Frankfurt am Main 88
Houston 86
Nürnberg 85
Princeton 85
Redwood City 85
Milan 84
Izmir 76
Nanchang 68
Shenyang 66
Lancaster 61
Seattle 61
Cattolica 60
Fairfield 51
Norwalk 49
Buffalo 48
Mountain View 48
Santa Clara 48
University Park 45
Chicago 44
Bremen 41
Munich 40
Rome 40
Jiaxing 39
Tianjin 39
Hangzhou 38
Rio de Janeiro 37
Changsha 36
Detroit 36
The Dalles 36
Hebei 35
Marseille 34
Redmond 34
Boardman 33
Kunming 33
Pune 31
Paris 29
Brussels 28
Abidjan 27
Nuremberg 27
Da Nang 26
Kent 26
Brasília 24
Haiphong 24
Orem 24
Zhengzhou 24
Baghdad 23
Brooklyn 23
Belo Horizonte 22
Curitiba 22
London 22
Council Bluffs 21
Guangzhou 21
Johannesburg 21
Chennai 20
Tashkent 20
Warsaw 20
Dhaka 19
Falls Church 19
Kraków 19
Phoenix 19
Simi Valley 19
Atlanta 18
Montreal 18
Mexico City 17
Amsterdam 16
San Francisco 16
Shanghai 16
Stockholm 16
Campinas 15
Denver 15
Ningbo 15
Quito 15
Washington 15
Totale 10.803
Salva come PNG Salva come JPEG
Nome #
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 365
Single-arm phase II study of conformal radiation therapy and temozolomide plus fractionated stereotactic conformal boost in high-grade gliomas: final report. 222
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 206
Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 202
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease 191
Organization of central nervous system dopaminergic pathways 187
Mutation screening of the DYT6/THAP1 gene in Italy 186
Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease 183
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 181
Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation 173
Relationships between disability, quality of life and prevalence of nonmotor symptoms in Parkinson's disease 171
Phenotypic characterisation of DYT13 primary torsion distonia. 168
Botulinum toxin in the treatment of outlet obstruction constipation due to puborectalis syndrome 160
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 157
Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia. Results of a randomised, placebo-controlled study. 156
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 154
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 153
Impulse control behaviours in patients with Parkinson's disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up 148
A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. 146
Clinical and genetic characteristics of late-onset Huntington's disease 146
Advances in the genetics of primary torsion dystonia 145
Choice-option evaluation is preserved in early Huntington and Parkinson's disease 145
Attentional networks in Parkinson's disease 145
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders 143
Analysis of blink rate in patients with blepharospasm 141
Botulinum toxin injected in the gastric wall reduces body weight and food intake rats. 140
Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up 140
Early DEtection of wEaring off in Parkinson disease: the DEEP study 140
Long-term outcome of subthalamic nucleus DBS in Parkinson's disease: from the advanced phase towards the late stage of the disease? 139
Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A. 138
Early versus delayed bilateral subthalamic deep brain stimulation for Parkinson’s disease: Need for long-term trials. 138
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 136
Substantia nigra in Parkinson's disease: a multimodal MRI comparison between early and advanced stages of the disease 136
Abnormal gating of somatosensory inputs in essential tremor. 134
Phenomenology and classification of dystonia: a consensus update 132
Motor features and response to oral levodopa in patients with Parkinson's disease under continuous dopaminergic infusion or deep brain stimulation 131
Alpha-synuclein gene duplication: marked intrafamilial variability in two novel pedigrees 130
Non-motor effects of deep brain stimulation of the subthalamic nucleus in Parkinson's disease. 129
Subclinical sensory abnormalities in unaffected PINK1 heterozygotes 129
Onset and progression of primary torsion dystonia in sporadic and familial cases 128
Behavioral and personality features in patients with lateralized Parkinson's disease 128
PINK1 mutations are associated with sporadic early-onset parkinsonism. 128
Management of bladder, prostatic and pelvic floor disorders 125
Isolated cervical dystonia: diagnosis and classification 124
Botulinum neurotoxin to treat chronic anal fissure: results of a randomized "Botox vs Dysport" controlled trial. 123
Isolated limb dystonia as presenting feature of Parkin disease 123
Gastroenterologia. 122
Botulinum neurotoxins for post-stroke spasticity in adults: A systematic review. 122
Smooth muscle spasms and sphincters. 119
Dystonic tremor 119
Dystonia: diagnosis and management 119
Aging is associated with a diffuse impairment of forebrain cholinergic neurons 118
A neurophysiological study of myoclonus in patients with DYT11 myoclonus-dystonia syndrome 118
A 52-Year-Old Man with Myoclonic Jerks 118
Primary dystonias 117
Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation 117
Quantitative gait analysis in parkin disease: Possible role of dystonia 117
Design and Operation of the Lombardy Parkinson's Disease Network 117
Impulse control behavior in GBA-mutated parkinsonian patients 117
DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13-36.32 in a Italian family with cranial-cervical or upper limb onset. 116
EFNS guidelines on diagnosis and treatment of primary dystonias 116
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease 116
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration 115
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis 114
Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis 114
Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study 114
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. 113
Primary focal hyperhidrosis in a new family not linked to known loci 113
Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease 113
Treatment with botulinum neurotoxin of gastrointestinal smooth muscles and sphincter spasms. 111
Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation 110
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 110
Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial 110
Choline acetyltransferase (ChAT) activity differs in right and left human temporal lobes 109
Dystonia rating scales: critique and recommendations 109
Shifting from constant-voltage to constant-current in Parkinson's disease patients with chronic stimulation 109
Dihydroergocriptine in Parkinson's disease: clinical efficacy and comparison with other dopamine agonists. 108
Peripheral neuropathy in the course of progressive systemic sclerosis: light and ultrastructural study 108
Genome-wide association study in musician's dystonia: A risk variant at the arylsulfatase G locus? 105
Failure of pallidal deep brain stimulation in DYT12-ATP1A3 dystonia 105
Is this dystonia? 104
Age-dependent loss of cholinergic neurones in basal ganglia of rats 104
Pathological gambling in Parkinson's disease: subthalamic oscillations during economics decisions 104
Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review 104
Indocyanine green video-angiography in neurosurgery: A glance beyond vascular applications 104
Early visual memory deficits: a neuropsychological marker of GBA mutations in PD? 103
Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease 103
Correction to: The Italian Dystonia Registry: rationale, design and preliminary findings (Neurological Sciences, (2017), 38, 5, (819-825), 10.1007/s10072-017-2839-3) 103
Dystonia and tremor: the clinical syndromes with isolated tremor 102
Therapeutic advances in dystonia 100
Effectiveness of higher doses of botulinum toxin to induce healing in patients eith chronic anal fissure. 99
Subthalamic involvement in monetary reward and its dysfunction in parkinsonian gamblers 99
Organization of the ascending projections from the ventral tegmental area: a multiple fluorescent retrograde tracer study in the rat 98
Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. 97
Locus ceruleus somata contain both acetylcholin esterase and norepinephrine: direct histochemical demonstration on the same tissue section 97
Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36 97
Mitochondrial dysfunction in Parkinson disease: evidence in mutant PARK2 fibroblasts 97
Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement 97
Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site 97
Acetylcholinesterase and catecholamine distribution in the locus ceruleus of the rat 96
Totale 13.028
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.508
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021238 0 0 0 0 0 0 0 0 0 0 216 22
2021/20221.348 191 157 22 45 47 32 21 271 48 59 211 244
2022/20232.567 354 345 231 353 229 303 99 177 325 31 91 29
2023/20241.537 47 493 43 241 42 139 78 43 22 57 161 171
2024/20252.796 66 90 261 56 176 82 78 105 543 215 562 562
2025/20267.847 1.348 264 621 882 1.170 428 1.418 472 554 619 71 0
Totale 21.695